Valuation: Galenica AG

Market Cap 4.28B 5.29B 4.6B 3.93B 7.42B 505B 7.54B 50.48B 19.81B 252B 19.88B 19.44B 843B P/E 2026 *
25.1x
P/E 2027 * 20.7x
Enterprise Value 5.21B 6.44B 5.6B 4.78B 9.03B 615B 9.17B 61.41B 24.1B 306B 24.18B 23.65B 1,026B EV / Sales 2026 *
1.18x
EV / Sales 2027 * 1.14x
Free-Float
99.39%
Yield 2026 *
2.97%
Yield 2027 * 3.13%
1 day-1.02%
6 months-1.02%
Current year-1.02%
Current year 115
Extreme 115
115
1 year 105
Extreme 105
116.19
3 years 105
Extreme 105
116.19
5 years 75.25
Extreme 75.25
116.19
10 years 75.25
Extreme 75.25
116.19
Manager TitleAgeSince
Chief Executive Officer 59 2020-03-31
Director of Finance/CFO 44 2024-12-31
Chief Tech/Sci/R&D Officer 54 2021-12-31
Director TitleAgeSince
Director/Board Member 61 2017-12-31
Chairman 68 2023-05-02
Director/Board Member 49 2019-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-1.02%-.--% - - 5.29B
-1.08%+1.82%+22.52%+111.39% 100B
+1.30%+0.88%+47.46%+151.01% 53.87B
-0.68%+3.52%+2.80%+274.52% 23.74B
+0.60%+2.93%-12.64%-16.12% 8.37B
-1.29%+1.85%-33.43%-30.57% 7.56B
-1.53%+3.21%-7.75%-30.20% 6.92B
-1.14%-1.47%+23.29%+22.85% 6.16B
-.--%+2.79%-6.02%-3.62% 3.8B
-3.96%+0.23%+13.93%+17.03% 3.7B
Average -0.88%+1.43%+5.57%+55.14% 23.82B
Weighted average by Cap. -0.44%+1.68%+21.65%+118.65%

Financials

2026 *2027 *
Net sales 4.4B 5.43B 4.72B 4.04B 7.62B 519B 7.74B 51.83B 20.34B 258B 20.41B 19.96B 866B 4.53B 5.6B 4.87B 4.16B 7.86B 535B 7.98B 53.41B 20.96B 266B 21.03B 20.57B 892B
Net income 181M 224M 194M 166M 314M 21.34B 318M 2.13B 837M 10.62B 840M 821M 35.62B 208M 257M 223M 191M 360M 24.49B 365M 2.45B 960M 12.19B 964M 942M 40.88B
Net Debt 928M 1.15B 997M 852M 1.61B 109B 1.63B 10.93B 4.29B 54.48B 4.31B 4.21B 183B 869M 1.07B 933M 797M 1.51B 102B 1.53B 10.24B 4.02B 51.02B 4.03B 3.94B 171B
Logo Galenica AG
Galenica AG, previously Galenica Sante Ltd, is a Switzerland-based healthcare services and products provider. The Company's business i divided into three business sectors: Retail, Products & Brands, and Services. The Company manages a locally established pharmacies network in Switzerland. It develops and distributes its own product portfolio, as well as cooperates with a range of business partners, such as Pierre Fabre, Ales Groupe and Vitor Consumer Health for marketing and distribution of such brands as Perskindol, Triofan, A-Derma, Lierac, Phyto, Anti-Brumm and Algifor. Galenica Sante's Services business sector is responsible for management of such logistics sector companies as Galexis, Unione Farmaceutica Distribuzione, Alloga and Medifilm.
Employees
6,577
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
85.95CHF
Average target price
87.20CHF
Spread / Average Target
+1.45%

Quarterly revenue - Rate of surprise